Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Cognitive Neuroscience Market

ID: MRFR/HC/30491-HCR
100 Pages
Rahul Gotadki
Last Updated: April 24, 2026
Cognitive Neuroscience Market Research Report By Research Application (Neuroimaging, Behavioral Analysis, Cognitive Assessment, Electrophysiological Studies), By End User (Academic Institutions, Research Organizations, Healthcare Providers, Pharmaceutical Companies), By Product Type (Hardware, Software, Services), By Methodology (Functional Magnetic Resonance Imaging (fMRI), Electroencephalography (EEG), Transcranial Magnetic Stimulation (TMS)), By Funding Source (Government Grants, Private Investments, Industry Sponsorship) and  By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)  - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Research Application (USD Billion)
      1. 4.1.1 Neuroimaging
      2. 4.1.2 Behavioral Analysis
      3. 4.1.3 Cognitive Assessment
      4. 4.1.4 Electrophysiological Studies
    2. 4.2 Healthcare, BY End User (USD Billion)
      1. 4.2.1 Academic Institutions
      2. 4.2.2 Research Organizations
      3. 4.2.3 Healthcare Providers
      4. 4.2.4 Pharmaceutical Companies
    3. 4.3 Healthcare, BY Product Type (USD Billion)
      1. 4.3.1 Hardware
      2. 4.3.2 Software
      3. 4.3.3 Services
    4. 4.4 Healthcare, BY Methodology (USD Billion)
      1. 4.4.1 Functional Magnetic Resonance Imaging (fMRI)
      2. 4.4.2 Electroencephalography (EEG)
      3. 4.4.3 Transcranial Magnetic Stimulation (TMS)
    5. 4.5 Healthcare, BY Funding Source (USD Billion)
      1. 4.5.1 Government Grants
      2. 4.5.2 Private Investments
      3. 4.5.3 Industry Sponsorship
    6. 4.6 Healthcare, BY Region (USD Billion)
      1. 4.6.1 North America
        1. 4.6.1.1 US
        2. 4.6.1.2 Canada
      2. 4.6.2 Europe
        1. 4.6.2.1 Germany
        2. 4.6.2.2 UK
        3. 4.6.2.3 France
        4. 4.6.2.4 Russia
        5. 4.6.2.5 Italy
        6. 4.6.2.6 Spain
        7. 4.6.2.7 Rest of Europe
      3. 4.6.3 APAC
        1. 4.6.3.1 China
        2. 4.6.3.2 India
        3. 4.6.3.3 Japan
        4. 4.6.3.4 South Korea
        5. 4.6.3.5 Malaysia
        6. 4.6.3.6 Thailand
        7. 4.6.3.7 Indonesia
        8. 4.6.3.8 Rest of APAC
      4. 4.6.4 South America
        1. 4.6.4.1 Brazil
        2. 4.6.4.2 Mexico
        3. 4.6.4.3 Argentina
        4. 4.6.4.4 Rest of South America
      5. 4.6.5 MEA
        1. 4.6.5.1 GCC Countries
        2. 4.6.5.2 South Africa
        3. 4.6.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Neuroscience Technologies (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Cerebrum Inc (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 NeuroScience Solutions (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cognitive Dynamics (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Brain Health Innovations (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 NeuroTech Labs (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Mind Research Institute (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Cognitive Neuroscience Group (GB)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY RESEARCH APPLICATION
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY PRODUCT TYPE
    6. 6.6 US MARKET ANALYSIS BY METHODOLOGY
    7. 6.7 US MARKET ANALYSIS BY FUNDING SOURCE
    8. 6.8 CANADA MARKET ANALYSIS BY RESEARCH APPLICATION
    9. 6.9 CANADA MARKET ANALYSIS BY END USER
    10. 6.10 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    11. 6.11 CANADA MARKET ANALYSIS BY METHODOLOGY
    12. 6.12 CANADA MARKET ANALYSIS BY FUNDING SOURCE
    13. 6.13 EUROPE MARKET ANALYSIS
    14. 6.14 GERMANY MARKET ANALYSIS BY RESEARCH APPLICATION
    15. 6.15 GERMANY MARKET ANALYSIS BY END USER
    16. 6.16 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    17. 6.17 GERMANY MARKET ANALYSIS BY METHODOLOGY
    18. 6.18 GERMANY MARKET ANALYSIS BY FUNDING SOURCE
    19. 6.19 UK MARKET ANALYSIS BY RESEARCH APPLICATION
    20. 6.20 UK MARKET ANALYSIS BY END USER
    21. 6.21 UK MARKET ANALYSIS BY PRODUCT TYPE
    22. 6.22 UK MARKET ANALYSIS BY METHODOLOGY
    23. 6.23 UK MARKET ANALYSIS BY FUNDING SOURCE
    24. 6.24 FRANCE MARKET ANALYSIS BY RESEARCH APPLICATION
    25. 6.25 FRANCE MARKET ANALYSIS BY END USER
    26. 6.26 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    27. 6.27 FRANCE MARKET ANALYSIS BY METHODOLOGY
    28. 6.28 FRANCE MARKET ANALYSIS BY FUNDING SOURCE
    29. 6.29 RUSSIA MARKET ANALYSIS BY RESEARCH APPLICATION
    30. 6.30 RUSSIA MARKET ANALYSIS BY END USER
    31. 6.31 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    32. 6.32 RUSSIA MARKET ANALYSIS BY METHODOLOGY
    33. 6.33 RUSSIA MARKET ANALYSIS BY FUNDING SOURCE
    34. 6.34 ITALY MARKET ANALYSIS BY RESEARCH APPLICATION
    35. 6.35 ITALY MARKET ANALYSIS BY END USER
    36. 6.36 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    37. 6.37 ITALY MARKET ANALYSIS BY METHODOLOGY
    38. 6.38 ITALY MARKET ANALYSIS BY FUNDING SOURCE
    39. 6.39 SPAIN MARKET ANALYSIS BY RESEARCH APPLICATION
    40. 6.40 SPAIN MARKET ANALYSIS BY END USER
    41. 6.41 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    42. 6.42 SPAIN MARKET ANALYSIS BY METHODOLOGY
    43. 6.43 SPAIN MARKET ANALYSIS BY FUNDING SOURCE
    44. 6.44 REST OF EUROPE MARKET ANALYSIS BY RESEARCH APPLICATION
    45. 6.45 REST OF EUROPE MARKET ANALYSIS BY END USER
    46. 6.46 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    47. 6.47 REST OF EUROPE MARKET ANALYSIS BY METHODOLOGY
    48. 6.48 REST OF EUROPE MARKET ANALYSIS BY FUNDING SOURCE
    49. 6.49 APAC MARKET ANALYSIS
    50. 6.50 CHINA MARKET ANALYSIS BY RESEARCH APPLICATION
    51. 6.51 CHINA MARKET ANALYSIS BY END USER
    52. 6.52 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    53. 6.53 CHINA MARKET ANALYSIS BY METHODOLOGY
    54. 6.54 CHINA MARKET ANALYSIS BY FUNDING SOURCE
    55. 6.55 INDIA MARKET ANALYSIS BY RESEARCH APPLICATION
    56. 6.56 INDIA MARKET ANALYSIS BY END USER
    57. 6.57 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    58. 6.58 INDIA MARKET ANALYSIS BY METHODOLOGY
    59. 6.59 INDIA MARKET ANALYSIS BY FUNDING SOURCE
    60. 6.60 JAPAN MARKET ANALYSIS BY RESEARCH APPLICATION
    61. 6.61 JAPAN MARKET ANALYSIS BY END USER
    62. 6.62 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    63. 6.63 JAPAN MARKET ANALYSIS BY METHODOLOGY
    64. 6.64 JAPAN MARKET ANALYSIS BY FUNDING SOURCE
    65. 6.65 SOUTH KOREA MARKET ANALYSIS BY RESEARCH APPLICATION
    66. 6.66 SOUTH KOREA MARKET ANALYSIS BY END USER
    67. 6.67 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    68. 6.68 SOUTH KOREA MARKET ANALYSIS BY METHODOLOGY
    69. 6.69 SOUTH KOREA MARKET ANALYSIS BY FUNDING SOURCE
    70. 6.70 MALAYSIA MARKET ANALYSIS BY RESEARCH APPLICATION
    71. 6.71 MALAYSIA MARKET ANALYSIS BY END USER
    72. 6.72 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    73. 6.73 MALAYSIA MARKET ANALYSIS BY METHODOLOGY
    74. 6.74 MALAYSIA MARKET ANALYSIS BY FUNDING SOURCE
    75. 6.75 THAILAND MARKET ANALYSIS BY RESEARCH APPLICATION
    76. 6.76 THAILAND MARKET ANALYSIS BY END USER
    77. 6.77 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    78. 6.78 THAILAND MARKET ANALYSIS BY METHODOLOGY
    79. 6.79 THAILAND MARKET ANALYSIS BY FUNDING SOURCE
    80. 6.80 INDONESIA MARKET ANALYSIS BY RESEARCH APPLICATION
    81. 6.81 INDONESIA MARKET ANALYSIS BY END USER
    82. 6.82 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    83. 6.83 INDONESIA MARKET ANALYSIS BY METHODOLOGY
    84. 6.84 INDONESIA MARKET ANALYSIS BY FUNDING SOURCE
    85. 6.85 REST OF APAC MARKET ANALYSIS BY RESEARCH APPLICATION
    86. 6.86 REST OF APAC MARKET ANALYSIS BY END USER
    87. 6.87 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    88. 6.88 REST OF APAC MARKET ANALYSIS BY METHODOLOGY
    89. 6.89 REST OF APAC MARKET ANALYSIS BY FUNDING SOURCE
    90. 6.90 SOUTH AMERICA MARKET ANALYSIS
    91. 6.91 BRAZIL MARKET ANALYSIS BY RESEARCH APPLICATION
    92. 6.92 BRAZIL MARKET ANALYSIS BY END USER
    93. 6.93 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    94. 6.94 BRAZIL MARKET ANALYSIS BY METHODOLOGY
    95. 6.95 BRAZIL MARKET ANALYSIS BY FUNDING SOURCE
    96. 6.96 MEXICO MARKET ANALYSIS BY RESEARCH APPLICATION
    97. 6.97 MEXICO MARKET ANALYSIS BY END USER
    98. 6.98 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    99. 6.99 MEXICO MARKET ANALYSIS BY METHODOLOGY
    100. 6.100 MEXICO MARKET ANALYSIS BY FUNDING SOURCE
    101. 6.101 ARGENTINA MARKET ANALYSIS BY RESEARCH APPLICATION
    102. 6.102 ARGENTINA MARKET ANALYSIS BY END USER
    103. 6.103 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    104. 6.104 ARGENTINA MARKET ANALYSIS BY METHODOLOGY
    105. 6.105 ARGENTINA MARKET ANALYSIS BY FUNDING SOURCE
    106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY RESEARCH APPLICATION
    107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY METHODOLOGY
    110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNDING SOURCE
    111. 6.111 MEA MARKET ANALYSIS
    112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY RESEARCH APPLICATION
    113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY END USER
    114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY METHODOLOGY
    116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY FUNDING SOURCE
    117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY RESEARCH APPLICATION
    118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY END USER
    119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY METHODOLOGY
    121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY FUNDING SOURCE
    122. 6.122 REST OF MEA MARKET ANALYSIS BY RESEARCH APPLICATION
    123. 6.123 REST OF MEA MARKET ANALYSIS BY END USER
    124. 6.124 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    125. 6.125 REST OF MEA MARKET ANALYSIS BY METHODOLOGY
    126. 6.126 REST OF MEA MARKET ANALYSIS BY FUNDING SOURCE
    127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
    128. 6.128 RESEARCH PROCESS OF MRFR
    129. 6.129 DRO ANALYSIS OF HEALTHCARE
    130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
    133. 6.133 HEALTHCARE, BY RESEARCH APPLICATION, 2024 (% SHARE)
    134. 6.134 HEALTHCARE, BY RESEARCH APPLICATION, 2024 TO 2035 (USD Billion)
    135. 6.135 HEALTHCARE, BY END USER, 2024 (% SHARE)
    136. 6.136 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    137. 6.137 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    138. 6.138 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    139. 6.139 HEALTHCARE, BY METHODOLOGY, 2024 (% SHARE)
    140. 6.140 HEALTHCARE, BY METHODOLOGY, 2024 TO 2035 (USD Billion)
    141. 6.141 HEALTHCARE, BY FUNDING SOURCE, 2024 (% SHARE)
    142. 6.142 HEALTHCARE, BY FUNDING SOURCE, 2024 TO 2035 (USD Billion)
    143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.2.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.2.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.2.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.2.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.3.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.3.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.3.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.3.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.4.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.4.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.4.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.4.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.5.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.5.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.5.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.5.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.6.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.6.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.6.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.6.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.7.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.7.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.7.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.7.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.8.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.8.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.8.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.8.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.9.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.9.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.9.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.9.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.10.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.10.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.10.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.10.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.11.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.11.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.11.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.11.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.12.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.12.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.12.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.12.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.13.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.13.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.13.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.13.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.14.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.14.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.14.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.14.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.15.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.15.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.15.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.15.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.16.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.16.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.16.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.16.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.17.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.17.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.17.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.17.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.18.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.18.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.18.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.18.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.19.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.19.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.19.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.19.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.20.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.20.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.20.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.20.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.21.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.21.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.21.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.21.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.22.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.22.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.22.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.22.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.23.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.23.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.23.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.23.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.24.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.24.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.24.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.24.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.25.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.25.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.25.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.25.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.26.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.26.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.26.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.26.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.27.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.27.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.27.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.27.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.28.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.28.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.28.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.28.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.29.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.29.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.29.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.29.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY RESEARCH APPLICATION, 2025-2035 (USD Billion)
      2. 7.30.2 BY END USER, 2025-2035 (USD Billion)
      3. 7.30.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. 7.30.4 BY METHODOLOGY, 2025-2035 (USD Billion)
      5. 7.30.5 BY FUNDING SOURCE, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Healthcare Market Segmentation

Healthcare By Research Application (USD Billion, 2025-2035)

  • Neuroimaging
  • Behavioral Analysis
  • Cognitive Assessment
  • Electrophysiological Studies

Healthcare By End User (USD Billion, 2025-2035)

  • Academic Institutions
  • Research Organizations
  • Healthcare Providers
  • Pharmaceutical Companies

Healthcare By Product Type (USD Billion, 2025-2035)

  • Hardware
  • Software
  • Services

Healthcare By Methodology (USD Billion, 2025-2035)

  • Functional Magnetic Resonance Imaging (fMRI)
  • Electroencephalography (EEG)
  • Transcranial Magnetic Stimulation (TMS)

Healthcare By Funding Source (USD Billion, 2025-2035)

  • Government Grants
  • Private Investments
  • Industry Sponsorship